For example, owing to differences in the function and distribution of the angiotensin converting enzyme 2 (ACE2) receptor, the efficacy of viral vector-based mucosal coronavirus disease 2019 (COVID-19) vaccines tested in WT mice is opposite that of NHPs or humans [4, 7–10]. Here, ACE2 is linked to COVID-19.